We did not estimate the effect this might have on overall progression to eligibility, although the estimates would be unlikely to change substantially as the majority of TB cases and pregnancies are associated with CD4 cell counts < 350 cells/μl in South Africa [19],[20]. The gene discussed is CD4; the disease is tuberculosis.